[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605465":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":10,"centralContacts":29,"locations":37,"responsibleParty":54,"collaborators":56,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":10,"eligibilityCriteria":71,"healthyVolunteers":67,"sex":72,"minAge":73,"maxAge":10,"enrollmentInfo":74,"targetDuration":10,"studyType":77,"phases":10,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":85,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Henan University of Traditional Chinese Medicine","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Traditional Chinese Medicine cohort",null,"IPF subjects who have continuously used traditional Chinese medicine for standardized treatment for 3 months or more within 1 year, or have accumulated treatment time for 6 months or more, are classified into the traditional Chinese medicine cohort.",[13],"Drug: Traditional Chinese medicine (TCM)",{"label":15,"type":10,"description":16,"interventionNames":17},"Non-Traditional Chinese Medicine cohort","Other IPF patients who do not meet the inclusion criteria for traditional Chinese medicine cohort, are classified into the non-traditional Chinese medicine cohort.",[18],"Drug: Non-traditional Chinese medicine (non-TCM)",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DRUG","Traditional Chinese medicine (TCM)","Regulated use of Chinese medicine treatment protocols is included as an exposure factor. Exposure is defined as taking the medication continuously for more than 3 months per year, or intermittently for more than 6 months per year. According to the standardised use of TCM protocols, the group is divided into an exposed group (TCM cohort) and an unexposed group (non-TCM cohort).",[9],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"Non-traditional Chinese medicine (non-TCM)","All intervention measures that do not meet the criteria for TCM exposure are regarded as non-TCM exposure.",[15],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"xueqing yu, Ph.D","CONTACT","+8613525518843","yxqshi@163.com",{"name":36,"role":32,"phone":10,"phoneExt":10,"email":10},"jiansheng li, Professor",[38],{"facility":39,"status":10,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"The First Affiliated Hospital of Henan University of Chinese Medicine","Zhengzhou","Henan","450000","China","CN",{"type":46,"coordinates":47},"Point",[48,49],113.64861,34.75778,{"lat":49,"lon":48},[52,53],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},{"name":36,"role":32,"phone":10,"phoneExt":10,"email":10},{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[57,59,61,63],{"name":58,"class":6},"The First Affiliated Hospital of Henan University of Traditional Chinese Medicine",{"name":60,"class":6},"China-Japan Friendship Hospital",{"name":62,"class":6},"The First Affiliated Hospital of Zhengzhou University",{"name":64,"class":6},"Shanghai Pulmonary Hospital, Shanghai, China","100605465","idiopathic-pulmonary-fibrosis-cohort-of-tcm-100605465",false,"NCT07162870","Idiopathic Pulmonary Fibrosis Cohort of TCM","Idiopathic Pulmonary Fibrosis Cohort Studies of Chinese Medicine","Inclusion Criteria:\n\n1. Patients diagnosed with IPF;\n2. Age ≥ 40 years old;\n3. Voluntary participation in this study,And sign the informed consent form.\n\nExclusion Criteria:\n\n1. Patients with confusion, dementia, consciousness disorders, and various mental illnesses;\n2. Patients who are unable to take care of themselves and have been bedridden for a long time.","ALL","40 Years",{"count":75,"type":76},1000,"ESTIMATED","OBSERVATIONAL","This study, based on past registration records, evaluates the clinical efficacy of traditional Chinese medicine in treating IPF in the real world, identifies advantageous populations and clinical targets, and provides references for precision traditional Chinese medicine treatment.",[80],"Idiopathic Pulmonary Fibrosis (IPF)",[82,83,84],"Idiopathic Pulmonary Fibrosis","TCM","Cohort","NOT_YET_RECRUITING","2025-08-31",{"date":88,"type":89},"2025-09-09","ACTUAL",{"date":91,"type":76},"2025-09-05",{"date":93,"type":76},"2028-11-30",{"name":5,"class":6},1]